TY  - JOUR
AU  - Feng, Felix Y
AU  - Thomas, Shibu
AU  - Saad, Fred
AU  - Gormley, Michael
AU  - Yu, Margaret K
AU  - Ricci, Deborah S
AU  - Rooney, Brendan
AU  - Brookman-May, Sabine
AU  - McCarthy, Sharon
AU  - Olmos, David
AU  - Chowdhury, Simon
AU  - Hadaschik, Boris
AU  - Liu, Yang
AU  - Davicioni, Elai
AU  - Smith, Matthew R
AU  - Small, Eric J
PY  - 2021
DO  - 10.1001/jamaoncol.2021.1463
UR  - http://hdl.handle.net/10668/17947
T2  - JAMA oncology
AB  - There is a need to identify prognostic biomarkers to guide treatment intensification in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC). To examine whether molecular subtypes predict response to apalutamide, using archived...
LA  - en
KW  - Aged
KW  - Aged, 80 and over
KW  - Androgen Antagonists
KW  - Androgen Receptor Antagonists
KW  - Cohort Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prostatic Neoplasms, Castration-Resistant
KW  - Thiohydantoins
KW  - Treatment Outcome
TI  - Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer.
TY  - research article
VL  - 7
ER  -